Temple University-of the Commonwealth System of Higher Education

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Biological Effects of Quercetin in COPD Phase II

Phase 2

Recruiting

Conditions: Chronic Obstructive Pulmonary Disease
Emphysema
Chronic Bronchitis With Airway Obstruction

Interventions: Drug: Quercetin 500 MG
Drug: Quercetin 1000 mg
Drug: Placebo

First Posted Date: 2023-08-21

Last Posted Date: 2024-04-08

Lead Sponsor: Temple University

Target Recruit Count: 30

Registration Number: NCT06003270

Locations: 🇺🇸
Nathaniel Marchetti, Philadelphia, Pennsylvania, United States

Forging Sustainable Solutions for HIV Continuity of Care Through Medical-legal Partnerships

Phase 1

Recruiting

Conditions: Organizational Partnerships for Healthy Living
Standard of Care

Interventions: Behavioral: Organizational Partnerships for Healthy Living
Behavioral: Standard of Care

First Posted Date: 2023-06-22

Last Posted Date: 2023-06-23

Lead Sponsor: Temple University

Target Recruit Count: 200

Registration Number: NCT05912842

Locations: 🇺🇸
TPAC, Philadelphia, Pennsylvania, United States

Clavulanic Acid for the Treatment of Cocaine Use Disorder

Phase 2

Active, not recruiting

Conditions: Cocaine Dependence

Interventions: Drug: Clavulanic Acid Only Product
Drug: Placebo

First Posted Date: 2022-09-30

Last Posted Date: 2024-05-02

Lead Sponsor: Temple University

Target Recruit Count: 65

Registration Number: NCT05562349

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
MUSC, Charleston, South Carolina, United States

The Path to Optimal Black Maternal Heart Health: Comparing Two CVD Risk Reduction Interventions (Change of HEART)

Not Applicable

Recruiting

Conditions: Hypertension
Pregnancy Related
Obesity
Racism

Interventions: Behavioral: COH
Behavioral: COH+

First Posted Date: 2022-08-12

Last Posted Date: 2024-12-05

Lead Sponsor: Temple University

Target Recruit Count: 432

Registration Number: NCT05499507

Locations: 🇺🇸
Temple University/Temple Health, Philadelphia, Pennsylvania, United States

Machine Learning to Reduce Hypertension Treatment Clinical Inertia

Not Applicable

Not yet recruiting

Conditions: Hypertension

Interventions: Other: Predicted uncontrolled BP status (yes/no) at follow up visit, derived using a machine learning algorithm

First Posted Date: 2022-06-06

Last Posted Date: 2024-06-14

Lead Sponsor: Temple University

Target Recruit Count: 100

Registration Number: NCT05406336

Immunological Basis for Mepolizumab Activity in COPD

Phase 2

Not yet recruiting

Conditions: COPD

Interventions: Drug: Mepolizumab 100 MG

First Posted Date: 2022-04-11

Last Posted Date: 2023-04-07

Lead Sponsor: Temple University

Target Recruit Count: 30

Registration Number: NCT05320939

Using Smartphones to Improve Physical Activity Levels of Individuals With Spinal Cord Injury

Phase 2

Recruiting

Conditions: Spinal Cord Injuries

Interventions: Behavioral: WI program
Behavioral: WI Program Reminder
Behavioral: JITAI Goal Setting
Behavioral: JITAI physical activity message
Other: Notification EMA
Other: End of day EMA
Other: Wake up time EMA
Other: Weekly PA Information
Other: Daily PA Information

First Posted Date: 2022-04-08

Last Posted Date: 2024-07-24

Lead Sponsor: Temple University

Target Recruit Count: 196

Registration Number: NCT05317832

Locations: 🇺🇸
Temple University, Philadelphia, Pennsylvania, United States

Immunological Basis for Benralizumab Activity in Chronic Obstructive Pulmonary Disease (COPD)

Phase 2

Not yet recruiting

Conditions: Chronic Obstructive Pulmonary Disease (COPD)

Interventions: Other: Comparison (control) group; no intervention
Other: Benralizumab placebo
Drug: Benralizumab

First Posted Date: 2022-03-10

Last Posted Date: 2023-04-07

Lead Sponsor: Temple University

Target Recruit Count: 45

Registration Number: NCT05273359

Association Between Types of Pain and Motor Activities Physical Activity

Completed

Conditions: Chronic Pain
Spinal Cord Injury

First Posted Date: 2022-02-11

Last Posted Date: 2023-03-14

Lead Sponsor: Temple University

Target Recruit Count: 17

Registration Number: NCT05236933

Locations: 🇺🇸
Temple University, Philadelphia, Pennsylvania, United States

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

Not Applicable

Recruiting

Conditions: COPD

Interventions: Device: myAirvo3
Device: Pulse oximeter

First Posted Date: 2022-01-24

Last Posted Date: 2024-11-22

Lead Sponsor: Temple University

Target Recruit Count: 642

Registration Number: NCT05204888

Locations: 🇺🇸
NewGen Health Group, Miami, Florida, United States
🇺🇸
UAB School of Medicine/Lung Health Center, Birmingham, Alabama, United States
🇺🇸
University of Florida, Jacksonville, Jacksonville, Florida, United States

and more 15 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy